IE
SRPT icon

Israel Englander’s Sarepta Therapeutics SRPT Stock Holding History

Israel Englander’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,200
Closed -$2.58M – 6379
2024
Q4 		$2.58M Sell
21,200
-11,500
-35% -$1.41M ﹤0.01% 3423
2024
Q3 		$4.08M Buy
32,700
+5,300
+19% +$733K ﹤0.01% 3023
2024
Q2 		$4.33M Buy
27,400
+7,900
+41% +$1.01M ﹤0.01% 2857
2024
Q1 		$2.52M Sell
19,500
-5,400
-22% -$661K ﹤0.01% 3518
2023
Q4 		$2.4M Sell
24,900
-47,300
-66% -$4.54M ﹤0.01% 3459
2023
Q3 		$8.75M Buy
+72,200
New +$8.16M ﹤0.01% 2172
2023
Q2 		– Sell
-22,500
Closed -$3.1M – 6661
2023
Q1 		$3.1M Buy
+22,500
New +$2.92M ﹤0.01% 3022
2021
Q3 		– Sell
-11,000
Closed -$855K – 7229
2021
Q2 		$855K Buy
+11,000
New +$834K ﹤0.01% 4809
2021
Q1 		– Sell
-41,000
Closed -$6.99M – 6488
2020
Q4 		$6.99M Sell
41,000
-14,900
-27% -$2.21M 0.01% 2125
2020
Q3 		$7.85K Buy
+55,900
New +$8.5M 0.01% 1460
2020
Q2 		– Sell
-4,100
Closed -$401K – 4578
2020
Q1 		$401K Buy
+4,100
New +$469K ﹤0.01% 3013
2018
Q2 		– Sell
-100,000
Closed -$7.41M – 4148
2018
Q1 		$7.41M Buy
+100,000
New +$6.67M 0.01% 1545
2016
Q3 		– Sell
-125,000
Closed -$2.38M – 3587
2016
Q2 		$2.38M Buy
+125,000
New +$2.32M 0.01% 1688
2016
Q1 		– Sell
-250,000
Closed -$9.64M – 3635
2015
Q4 		$9.64M Buy
+250,000
New +$8.11M 0.02% 942

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Israel Englander's SRPT Position: Q2 2026 in Review

Israel Englander reduced its Sarepta Therapeutics (SRPT) stake by 2.3% in Q2 2026, selling an estimated $534K and leaving 1,193,468 shares worth $21.4M. The position accounts for 0.01% of the portfolio, ranked #1558.

Israel Englander first reported a position in SRPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $120M in Q3 2016. 320 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Israel Englander held 1,193,468 shares of Sarepta Therapeutics worth $21.4M as of Q2 2026.
  • Israel Englander sold 28,214 Sarepta Therapeutics shares in Q2 2026, an estimated $534K.
  • Sarepta Therapeutics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1558 holding.
  • Israel Englander first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Israel Englander's Sarepta Therapeutics position peaked at $120M in Q3 2016.
  • 320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.